Cargando…
Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
Infection with SARS-CoV-2 causes the coronavirus infectious disease 2019 (COVID-19), a pandemic that has, at present, infected more than 11 million people globally. Some COVID-19 patients develop a severe and critical illness, spurred on by excessive inflammation that can lead to respiratory or mult...
Autores principales: | Cheah, Irwin K., Halliwell, Barry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402156/ https://www.ncbi.nlm.nih.gov/pubmed/32646061 http://dx.doi.org/10.3390/antiox9070595 |
Ejemplares similares
-
Ergothioneine, recent developments
por: Cheah, Irwin K., et al.
Publicado: (2021) -
Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues
por: Tang, Richard Ming Yi, et al.
Publicado: (2018) -
Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023) -
Effect of Ergothioneine on 7-Ketocholesterol-Induced Endothelial Injury
por: Koh, Sally Shuxian, et al.
Publicado: (2020) -
Protective Effect of Ergothioneine against 7-Ketocholesterol-Induced Mitochondrial Damage in hCMEC/D3 Human Brain Endothelial Cells
por: Leow, Damien Meng-Kiat, et al.
Publicado: (2023)